A strain of Trichomonas vaginalis infected with a double-stranded RNA virus showed pronounced cytopathology in the form of giant syncytia generated by the recruitment of single cells. The giant cells ultimately lysed, releasing virus into the culture medium. In the infected cells, clusters of electron-dense particles resembling viral structures were found in the cytoplasm. In addition, distinctive inclusions composed of similar particles were present in the nuclei of some cells. Double-stranded viral RNA of 5.5 kbp was demonstrated in both cytoplasmic and nuclear fractions from these cells. Viral particles collected from the cell-free culture supernatant were of the same shape and size as the RNA virus isolated from a strain of T. vaginalis described previously (Wang and Wang, Journal of Biological Chemistry, 260: 3697-3702, 1985; Wang and Wang, Proceedings of the National Academy of Sciences of the U.S.A. 83: 7956-7986) which does not show this cytopathology.

Trichomonas vaginalis is a sexually-transmitted parasite that is the causative agent in the disease trichomoniasis. Resistance to the only FDA-approved medication to this disease, metronidazole, has been on the increase giving rise to the need for finding targets for new inhibitors to exploit. New inhibitors can target enzymes such as 4-coumarate:CoA ligase and S-adenosylhomocysteine hydrolase. Another potential target is a cathepsin D-like protease found in T. vaginalis . This aspartic protease in humans is responsible for degrading proteins in the lysosome, and degrading hemoglobin in P. falciparum as the homologue plasmepsin. Searching the gene database, only one cathepsin-D like protease was discovered throughout the organism's genome. Utilizing RT-PCR, this gene is found to be expressed in two different strains of the organism. Transfection of an epitope-tagged version of this cathepsin D-like protease into T. vaginalis was accomplished, and subsequent immunofluorescence of this tagged version shows it to be localized in intracellular compartments, which can be colocalized using the SNARE and VAMP proteins found in T. vaginalis .

L'objectif de ce travail consiste en la synthèse de nouveaux 5-nitroimidazoles fonctionnalisés à visée thérapeutique. Dans un premier temps, l'étude de la réactivité du 4-bromo-1,2-diméthyl-5-nitro-1H-imidazole vis-à-vis du couplage de Suzuki-Miyaura sous irradiation micro-ondes a permis la synthèse de nouveaux produits substitués en position 4 par différents groupements aryle ou styryle. Dans un second temps, la réactivité LD-SRN1 a été étudiée entre le 4-[4-(chlorométhyl)phényl]-1,2-diméthyl-5-nitro-1H-imidazole et différents nucléophiles centrés sur l'atome de carbone ou de soufre. Cette étude a révélé l'importance de la température dans l'activation de la réaction par transfert monoélectronique. De nouveaux dérivés substitués en position 4 par divers groupements sulfonyles ont ensuite été synthétisés, par réactions SN2 et SNAr entre des dérivés 5-nitroimidazolés et différents anions sulfinates. Cette synthèse a été suivie par la mise au point de tests biologiques sur Trichomonas vaginalis. L'activité trichomonacide a été évaluée sur certaines de ces molécules, à l'origine de relations structure-activité montrant l'influence de la position du groupement sulfonyle substituant le noyau 5-nitroimidazole. La dernière partie de ce travail décrit une réaction de O-arylation pallado-catalysée inattendue et originale, d'un dérivé fluoré en série nitro(o-nitrophényl)imidazole impliquant des acides arylboroniques dans les conditions opératoires de la réaction de Suzuki-Miyaura. / The aim of this work consists of the synthesis of new potentially bioactive functionalized 5-nitroimidazoles. Initially, the reactivity study of the 4-bromo-1,2-dimethyl-5-nitro-1H-imidazole under microwave-assisted Suzuki-Miyaura cross-coupling conditions gave new derivatives substituted by various aryl or styryl groups in 4-position. In a second step the 4-[4-(chloromethyl)phenyl]-1,2-dimethyl-5-nitro-1H-imidazole was prepared in order to study LD-SRN1 reactivity with different carbon and sulphur centered nucleophiles. This study pointed the role of the temperature for the electron transfer reactions. Then, new 4-position sulfonyl substituted derivatives were synthesized by SN2 and SNAr reactions between sulfinate anions and three substrates in 5-nitroimidazole series. This synthesis was followed by the development of biological assays on Trichomonas vaginalis. This assay was performed on some of these molecules, which revealed a relation between the structure and the position of the sulfonyl group and the antitrichomonas activity. The last part of this work describes an unexpected and original palladium-catalyzed O-arylation in fluorinated nitro(o-nitrophenyl)imidazole series involving arylboronic acids under Suzuki-Miyaura cross-coupling reaction conditions.

Selon les dernières estimations de l'OMS, on enregistre chaque année dans le monde 498.9 millions de nouveaux cas d'infections sexuellement transmissibles (IST) dont 276.4 millions sont dus au parasite Trichomonas vaginalis (T. vaginalis). Au niveau du tractus génital, la colonisation et l’irritation de la muqueuse vaginale par T. vaginalis favorisent la survenue de complications infectieuses. Ces infections associées peuvent conduire à des infections chroniques et avoir à terme des conséquences graves (stérilité, rupture prématuré du placenta, mort prématurée du nourrisson). De plus, ces infections vaginales représentent des facteurs qui favorisent les infections par le Virus d’Immunodéficience Humaine (VIH-1).A l’heure actuelle, la lutte contre ce type d’infections consiste à agir tant au niveau curatif, que préventif. Ainsi, l’objectif de ce projet est de développer de nouvelles formulations pour la prévention et le traitement des pathogènes qui colonisent les muqueuses vaginales. Dans ce contexte, la formulation que nous proposons est composée de metronidazole inclut dans un hydrogel thermogélifiant à base de pluronic® F127 et de chitosane. Il a été montré que cet hydrogel conserve ces propriétés physiques à une température physiologique même après dilution dans les fluides vaginaux. Ces hydrogels sont stables et permettent une libération prolongée du metronidazole. La formulation n’a montré aucune toxicité envers les cellules HeLa ni envers la muqueuse vaginale porcine. L’efficacité de cette formulation a été prouvée envers T. vaginalis et présente un effet protecteur envers les cellules HeLa en présence de T. vaginalis. L’ensemble des résultats suggère donc la capacité́ de cette formulation à constituer une double barrière, physique et pharmacologique, protectrice de la muqueuse vaginale vis-à-vis de T. vaginalis. / According to the latest WHO estimates, 498 millions of new cases of sexually transmitted infections (STIs) are recorded annually in the world, including 276.4 million due to the parasite Trichomonas vaginalis (T. vaginalis). In the genital tract colonization and irritation of the vaginal mucosa by T. vaginalis promote the occurrence of infectious complications. Associated infections can lead to chronic infections and eventually have serious consequences (infertility, premature placental abruption, premature death). In addition, these vaginal infections can promote infection by Human Immunodeficiency Virus (HIV-1).Currently, the fight against these infections is to act at curative and preventive level. Thus, the objective of this project is to develop new formulations for the prevention and treatment of pathogens that colonize the vaginal mucosa. In this context, we propose a formulation composed of metronidazole and chitosan include in a thermogelling hydrogel of pluronic F127®.It was shown that the hydrogel retains its physical properties even at a physiological temperature and after dilution in the vaginal fluids. These hydrogels are stable and allow a sustained release of the metronidazole. The formulation showed no toxicity against HeLa cells or porcine vaginal mucosa. The effectiveness of this formulation has been proven against T vaginalis and has a protective effect on HeLa cells in the presence of T. vaginalis. The overall results therefore suggest the ability of this formulation to form a double barrier, physical and pharmacological, than protect vaginal mucosa against T. vaginalis.

Ce travail de thèse est consacré à la synthèse et l’évaluation biologique de nouveaux nitromidazoles à potentialités anti-infectieuses. Dans les trois premiers chapitres, nous avons abordé les propriétés biologiques des 5-nitroimidazoles, et la synthèse de nouveaux composés fonctionnalisés en positions 2 et 4 dans le but d'améliorer l'activité sur les souches résistantes au métronidazole, le 5-nitroimidazole de référence, tout en contrôlant au mieux la mutagénicité. Nous avons développé une méthode de couplage régiosélectif de Suzuki-Miyaura en position 4 du 2,4-dibromo-1-méthyl-5-nitro-1H-imidazole, suivi d’un deuxième couplage de Suzuki-Miyaura ou de Sonogashira par méthodologie « one-pot » séquentielle en position 2. Cette méthodologie nous a permis d’obtenir 30 nouveaux composés qui ont été testés pour leur propriétés antibactériennes et antiparasitaires. Une dizaine de composés ont été synthétisés par méthodologie TDAE sur le 4-[4-(chlorométhyl)phényl]-1,2-diméthyl-5-nitro-1H-imidazole. Dans le dernier chapitre, nous avons initié un travail de pharmacomodulation en série imidazooxazole, motif bien connu pour ses propriétés antituberculeuses et antileishmaniennes. Nous avons présenté la synthèse et l’évaluation biologique de dérivés 5-nitroimidazooxazoles et 7-nitro-2,3-dihydroimidazo[5,1-b]oxazoles. La synthèse de dérivés 6-nitroimidazooxazoles fonctionnalisés en position 5 est en cours de développement et nous avons présenté quelques essais de CH-arylation sur le 2-méthyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole. / We have developed in this work the synthesis and the biological evaluation of novel nitromidazoles with anti-infectious potentialities. In the first three parts, we discussed the biological properties of 5-nitroimidazole scaffold, and the synthesis of new compounds functionalized at 2- and 4-position in order to improve the activity on metronidazole-resistant strains, while controlling mutagenicity. We developed a regioselective Suzuki-Miyaura cross- coupling reaction at 4-position of 2,4-dibromo-1-methyl-5-nitro-1H-imidazole, followed by a second Suzuki-Miyaura or Sonogashira cross-coupling reaction at 2-position by a "one-pot" sequential process. This methodology has enabled us to obtain 30 new products which were tested for their antibacterial and antiparasitic properties. Twelve compounds were synthesized by TDAE methodology on {4- [4- (chloromethyl) phenyl]} -1,2-dimethyl-5-nitro-1H-imidazole. In the last part, we initiated a work of pharmacomodulation in imidazooxazole series, scaffold well-known for its antituberculous and antileishmanial properties. We have described the synthesis and the biological evaluation of 6-functionalized 5-nitroimidazooxazole and 7-nitro-2,3-dihydroimidazo [5,1-b]oxazole derivatives. We have presented some CH-arylation assays on 2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole to obtain 5-functionalized 6-nitroimidazooxazole derivatives.

Trichomonas vaginalis is flagelated microaerophilic protozoan parasite from Excavata group, which causes trichomoniasis, the most common nonviral sexually transmitted disease in the world. It causes vaginitis in women and uretritis in man and it can also cause problems for example during pregnancy. This thesis is aimed on the characterisation of hydrogenosomal iron-sulfur flavoproteins (ISF) from Trichomonas vaginalis, proteins, which were only recently discovered in the proteome of hydrogenosome of T. vaginalis. Specifically, we have focused on characterisation of ISF3 which is, according to our data, active homodimer and binds flavin mononucleotide (FMN) and iron-sulphur centre in its active site. The iron- sulphur centre is not characterised yet. ISF3 is able to reduce oxygen, hydrogen peroxide, sodium nitrate and metronidazole also in the enzymatic system with PFO and ferredoxin. Next, I tried to reduce ammonium sulphate with ISF3, but unsuccessfully. These results correspond with the activities obtained for ISF from Methanosarcina thermophila, where ISF reduces oxygen and hydrogen peroxide to water. In addition, ISF3 is able to reduce nitrogen compounds. It is important according to the fact, that metronidazole is a drug from the group of 5−nitroimidazoles. The other results show the decrease...

A human safe, Alhydrogel adjuvanted whole cell Trichomonas vaginalis vaccine was tested for efficacy in a BALB/c mouse model of vaginal infection. Additionally, the systemic and local immune response were measured. Vaccination reduced incidence and increased clearance of infection, and induced both systemic and local humoral immune responses. CD4+ cells were detected in vaginal tissues following intravaginal challenge with T. vaginalis, but were not seen in uninfected mice. CD4+ cells were detected more often, earlier, and in greater numbers in vaccinated vaginal tissues compared to unvaccinated controls. Presence of CD4+ T cells following infection can have significant implications of increasing HIV susceptibility and transmission. These data suggest that the vaccine induces local and systemic immune responses, and confers significantly greater protection against vaginal challenge than unvaccinated vaginal challenge. These data support the potential for a human vaccine against T. vaginalis infection that could also impact the incidence of HIV infections.

A human safe, Alhydrogel adjuvanted whole cell Trichomonas vaginalis vaccine was tested for efficacy in a BALB/c mouse model of vaginal infection. Additionally, the systemic and local immune response were measured. Vaccination reduced incidence and increased clearance of infection, and induced both systemic and local humoral immune responses. CD4+ cells were detected in vaginal tissues following intravaginal challenge with T. vaginalis, but were not seen in uninfected mice. CD4+ cells were detected more often, earlier, and in greater numbers in vaccinated vaginal tissues compared to unvaccinated controls. Presence of CD4+ T cells following infection can have significant implications of increasing HIV susceptibility and transmission. These data suggest that the vaccine induces local and systemic immune responses, and confers significantly greater protection against vaginal challenge than unvaccinated vaginal challenge. These data support the potential for a human vaccine against T. vaginalis infection that could also impact the incidence of HIV infections.

No description available.

O presente trabalho teve por objetivo a avaliação físico-química e biológica de uma fração de saponinas enriquecida, obtida a partir de frutos verdes de Ilex paraguariensis A. St. Hil (mate). A espécie apresenta grande importância econômica para vários países sul-americanos, dentre eles o Brasil. Os frutos verdes da espécie acumulam significativa quantidade de saponinas, entretanto, são considerados subproduto da indústria do beneficiamento das folhas de mate. O extrato liofilizado dos frutos (EX40) foi obtido por turboextração na proporção planta-solvente de 1:10 utilizando como solvente solução hidroalcoólica a 40%. Para análise do extrato bruto foi desenvolvido e validado um método analítico por CLAE-UV, que permitiu: 1) quantificar o marcador químico ilexosídeo II em EX40; 2) estimar o conteúdo em saponinas totais do extrato, tendo sido obtidos valores de 8,2 g% e 47,6 g% respectivamente. Uma fração enriquecida em saponinas, denominada MSF, foi obtida mediante fracionamento em fase sólida a partir de EX40, utilizando resina hidrofóbica poliaromática e gradiente metanol:água de polaridade decrescente. Os maiores teores de saponinas foram obtidos para as frações contendo 70 e 90 % de metanol. A reprodutibilidade do processo foi avaliada por CLAE-UV, considerando o desvio padrão relativo (DPR) entre a área dos dois picos majoritários de MSF produzidas em seis lotes distintos. Valores de DPR de 8,17% para o pico I (ilexosídeo II) e 5,96 % para o pico II (majoritário) foram obtidos. A toxicidade da fração foi avaliada pelo potencial hemolítico in vitro e citotoxicidade sobre cultura de células de mamífero (MDBK ATCC CCL-22). Para atividade hemolítica foi determinado um valor de IC50 de 0,2 g/L (0,22 mM, expresso em ilexosídeo II). O valor de IC50 para citotoxicidade foi 3,8 g/L (4,04 mM, expresso em ilexosídeo II), caracterizando um produto de baixa toxicidade. Dentre as várias atividades biológicas descritas para saponinas, selecionouse avaliar MSF quanto ao seu potencial como imunoadjuvante, assim como a atividade tricomonicida. Para o primeiro caso, MSF foi testada em uma vacina contendo herpesvírus bovino tipo 5 como antígeno viral, nas doses de 100 e 500 μg. Entretanto, o incremento no título de IgG totais, avaliado por ELISA, não foi significativo. A atividade tricomonicida foi comparada aos tensoativos polissorbato 80 e tiloxapol e a uma fração enriquecida em saponinas de Quillaja saponaria. Após 24 h de incubação foi observado para MSF um efeito dose-dependente, atingindo letalidade total dos trofozoítos na concentração de 0,6 g/L. Esse efeito foi superior ao observado para polissorbato 80 e tiloxapol e similar ao de quillaia. O tratamento com metronidazol, administrado tanto após tratamento prévio dos trofozoítos com MSF quanto em associação com essa fração, não revelou qualquer alteração significativa no efeito de ambos os produtos, o que sugere ausência de interação entre MSF e MTZ e a possível existência de mecanismos de ação distintos. A caracterização físico-química enfatizou o estudo do tamanho e forma das micelas, seu comportamento reológico e capacidade de solubilizar compostos hidrofóbicos. A concentração micelar crítica foi determinada em 0,41 g/L utilizando um corante hidrofóbico como marcador. A análise por microscopia eletrônica de transmissão (MET) e CRIO-MET revelou a presença simultânea de micelas alongadas, com tamanho superior a 500 nm, e micelas esféricas de tamanho menor. Para a fração de micelas esféricas, a análise por espalhamento de nêutrons a baixo ângulo permitiu estabelecer diâmetro de 17,9 Å, perfazendo 23,1 e 32,6 % das micelas observadas em soluções de MSF a 0,5 e 1,0 % m/v, respectivamente. O comportamento reológico de MSF nas concentrações de 0,25 a 4,0 %, determinado por reometria dinâmica com controle de deformação, foi do tipo viscoelástico para todas as concentrações. Esse fato corrobora a existência de agregados não-esféricos, filiformes, semelhantes a micelas tipo wormlike. A solubilização micelar de fármacos mediante MSF foi avaliada utilizando como substâncias-modelos os fármacos flurbiprofeno – FLB (ácido fraco) e carbamazepina - CBZ (base fraca), ambos pouco solúveis, e saponinas de quillaia como produto de comparação. Nas concentrações de 0,13 a 1,5 % as saponinas de quillaia foram mais eficientes frente ao flurbiprofeno, enquanto MSF foi capaz de aumentar significativamente a solubilidade da carbamazepina. O incremento na solubilização gerado por MSF foi de 0,0145 e 0,0129 g/L para CBZ e FLB, respectivamente. / The present work aimed the physicochemical and biological evaluation of a saponin enriched fraction from the green fruits of Ilex paraguariensis A. St. Hil. (mate), a species of great economical importance in several Southern American countries, including Brazil. Despite possessing high amounts of saponins, mate green fruits have no commercial use to date and are considered a waste product from the mate leaves processing companies. Mate fruits lyophilized extract (EX40) was produced using turbo-extraction having a 40:60 mixture of water and ethanol as solvent and a 1:10 drug/solvent proportion. An HPLC-UV method was developed and validated aiming at: I) Quantify the EX40 chemical marker, ilexoside II; II) Determine the EX40 total saponin content. The values obtained were of 8.20 wt% and 47.60 wt%, respectively. An enriched saponin fraction (MSF) was obtained from EX40 through a solid phase extraction process within a polyaromatic resin and a decreasing solvent polarity gradient of methanol and water. The higher recovery of mate saponins was achieved with the 70 and 90 % methanol-containing fractions. The process reproducibility was assessed by HPLC-UV through the analysis of the relative standard deviation (RSD) of the two major MSF saponins peak areas obtained in six different batches. RSD values of 8.17 % for peak I (ilexoside II) and 5.96 % for peak II (major peak) were obtained. The MSF toxicity was evaluated according to its haemolytical activity and in vitro cytotoxicity against a mammalian cell culture lineage (MDBK ATCC CCL-22). Values of IC50 of 0.2 g/L (0.22 mM expressed as ilexoside II) and 3.8 g/L (4.04 mM as Ilexoside II) were found for the haemolysis and cytotoxicity respectively. Therefore we could classify MSF as a low toxicity product. Among the several biological activities ascribed to saponins, this work focused on the investigation of MSF immune enhancer potential and its anti-trichomonads vaginalis activity. For the first evaluation, MSF wad added to a bovine herpesvirus 5 vaccine, at 100 and 500 μg doses. However total IGg titres determined by ELISA were not statistically significant. The antitrichomonads activity of MSF was compared a saponin enriched fraction from the species Quillaja saponaria (Quillaja) and to tyloxapol and polysorbate 80. After 24h of incubation MSF presented a dose-dependent activity with total trophozoites lethality at a concentration of 0.6 g/L. The activity was higher than the synthetic surfactants and similar to Quillaja. The treatment with metronidazole (MTZ), peformed in association and after exposing the trophozoites with MSF did not show any synergistic effect of MZT and MSF which suggest an absence of interaction between the compounds and also that they probably have distinct mechanisms of action. The physicochemical evaluation of MSF focused the determination of MSF micelles size and shape, their rheological behaviour and ability to increase the solubility of hydrophobic compounds. MSF critical micellar concentration was determined as 0.41 g/L using a hydrophobic dye as a probe. The transmission electron microscopy (TEM) and CRYO-TEM analysis revealed the occurrence of filiform micelles higher than 500 nm and smaller sizes spherical micelles simultaneously. The spherical micelles radius of 17.9 Å were determined using small angle neutron scattering.and they corresponded to 23.1 and 32.6 % of the total micelles in MSF solutions of 0.5 and 1.0 % w/v, respectively. The rheological behavior of MSF ranging in concentration from 0.25 to 4.0% was determined on a dynamic strain control rheometer and a viscoelastic behavior was observed for all concentrations. These findings corroborate the occurrence of nonspherical micelles very long in size (wormlike). MSF ability to improve the solubilisation of poor aqueous soluble drugs was assessed using carbamazepine (CBZ) and flurbiprofen (FLB) as a model of amphiphilic basic and acidic coumpounds. Saponin enriched fractions were evaluated in concentrations ranging from 0.13 to 1.5 %. Quillaja was more efficient toward the weak acid while MSF was able to increase significantly the CBZ solubility. The increase on CBZ and FLB solubility after MSF addition was of 0.0145 and 0.0129 g/L, respectively.